Search

Your search keyword '"Colaianni G"' showing total 147 results

Search Constraints

Start Over You searched for: Author "Colaianni G" Remove constraint Author: "Colaianni G"
147 results on '"Colaianni G"'

Search Results

4. Stemness genes expression in naïve vs. osteodifferentiated human dental-derived stem cells

8. Irisin, the novel myokine responsible for benefits of physical exercise on bone

15. Effects of Arg-vasopressin on osteoblasts

17. Direct or oxytocin - mediated estrogen actions on bone

29. Irisin Levels in Cerebrospinal Fluid Correlate with Biomarkers and Clinical Dementia Scores in Alzheimer Disease.

30. Multiscale and multidisciplinary analysis of aging processes in bone.

31. Irisin prevents trabecular bone damage and tumor invasion in a mouse model of multiple myeloma.

32. LIGHT/TNFSF14 Affects Adipose Tissue Phenotype.

33. Irisin Protects against Loss of Trabecular Bone Mass and Strength in Adult Ovariectomized Mice by Stimulating Osteoblast Activity.

34. Short-Term Irisin Treatment Enhanced Neurotrophin Expression Differently in the Hippocampus and the Prefrontal Cortex of Young Mice.

35. Once-Daily Subcutaneous Irisin Administration Mitigates Depression- and Anxiety-like Behavior in Young Mice.

36. Vitamin D Increases Irisin Serum Levels and the Expression of Its Precursor in Skeletal Muscle.

37. Irisin Role in Chondrocyte 3D Culture Differentiation and Its Possible Applications.

38. Elevated Expression of ADAM10 in Skeletal Muscle of Patients with Idiopathic Inflammatory Myopathies Could Be Responsible for FNDC5/Irisin Unbalance.

39. Time-dependent unloading effects on muscle and bone and involvement of FNDC5/irisin axis.

40. Irisin Modulates Inflammatory, Angiogenic, and Osteogenic Factors during Fracture Healing.

41. Impact of 10-day bed rest on serum levels of irisin and markers of musculoskeletal metabolism.

42. Antidepressant Effect of Intermittent Long-Term Systemic Administration of Irisin in Mice.

43. Irisin Serum Levels and Skeletal Muscle Assessment in a Cohort of Charcot-Marie-Tooth Patients.

44. Irisin and Secondary Osteoporosis in Humans.

45. Systemic Administration of Recombinant Irisin Accelerates Fracture Healing in Mice.

47. The Novel Role of PGC1α in Bone Metabolism.

48. The Myokine Irisin Promotes Osteogenic Differentiation of Dental Bud-Derived MSCs.

49. The effect of Irisin on bone cells in vivo and in vitro.

50. Irisin Correlates Positively With BMD in a Cohort of Older Adult Patients and Downregulates the Senescent Marker p21 in Osteoblasts.

Catalog

Books, media, physical & digital resources